Inbx ticker
Web1 day ago · Inhibrx, Inc. (NASDAQ:INBX) is an under-the-radar developer of biologic therapeutics for cancer and rare diseases. Its latest stage candidate, INBRX-109, is in a phase 2 trial. Its latest stage ... WebStock Price and Dividend Data for Inhibrx Inc (INBX), including dividend dates, dividend yield, company news, and key financial metrics. ... Ticker Symbol Lookup. Quickly find stocks on the NYSE, NASDAQ and more. INBX:Inhibrx Inc - Stock Price Quote and Dividend Data. INBX. Inhibrx Inc. Add to Scorecard. INBX QUICK LINKS
Inbx ticker
Did you know?
WebApr 5, 2024 · Inhibrx Inc. (NASDAQ: INBX) stock closed at 17.84 per share at the end of the most recent trading day (a -4.95% change compared to the prior day closing price) with a volume of 374.18K shares and market capitalization of 756.41M. Is a component of indices and it is traded on NASDAQ exchange. http://openinsider.com/INBX
WebINBX Stock Data and Insider Activity. INBX insider trading, corporate lobbying, Congressional trading, social media sentiment, stock price movement, and more. INBX - Inhibrx, Inc. … WebMar 31, 2024 · Inhibrx, Inc. (INBX) Company Profile & Overview - Stock Analysis 18.87 +0.38 (2.01%) Overview Financials Statistics Forecast Dividends Profile Chart Company Description Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates.
WebINBX Complete Inhibrx Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. WebApr 10, 2024 · The majority of my post are the top 20% gainer! To decode them its (ticker ID, % Changed, Volume, Close price and Float) I typically put V,C&F as a prefix to that number and use K, M and B as a suffix (Kilo, Million & Billion) for volume and float. I may also use S for Support and R for Resistance.
Web22 hours ago · Inbox: This change fueled Kumar Rocker's dominant first start. The Arizona Fall League's top prospect and breakout player of the year in 2024 have wasted no time …
WebInhibrx Inc 's current Return on Assets, Investment, Equity ROE, ROI and ROA comparisons to Biotechnology & Pharmaceuticals Industry and Healthcare Sector, and S&P 500 philippshof altenhagenWebINBX insider trading, corporate lobbying, Congressional trading, social media sentiment, stock price movement, and more INBX - Inhibrx, Inc. Common Stock Inhibrx Inc is a clinical-stage biotechnology company focused on developing a … trust care agency scotlandWebInsider trades for Inhibrx, Inc. (INBX). Monitor SEC Form 4 Insider Trading Filings for Insider Buying and Selling. Real-time Insider Trading Stock Screener. ... Ticker Insider Name Title Trade Type Price Qty Owned ΔOwn Value 1d 1w 1m 6m; 2024-03-02 16:17:17. 2024-03-01. INBX: Eckelman Brendan P. Chief Scientific Officer: S - Sale: $24.21-40,000: philipps herbornWebJan 6, 2024 · Inhibrx, Inc. is a clinical-stage biotechnology company focused on developing a pipeline of biologic therapeutic candidates. The Company’s single domain antibody … philipps hesepeWebMar 6, 2024 · San Diego, CA, March 6, 2024 – Inhibrx, Inc. (Nasdaq: INBX) (“Inhibrx” or the “Company”), a biopharmaceutical company with four clinical programs in development and a strong emerging pipeline, t oday reported financial results for the fourth quarter and fiscal year 2024. Key Highlights philippshof wienWebFeb 28, 2024 · CIK: 1739614 Ticker: INBX. Earnings Press Release 10-K Annual Report 10-K YoY Changes Annual Proxy. Inhibrx, Inc. HISTORY TOOLS. CIK: 1739614 Ticker: INBX. … philipps hof saaleWebApr 12, 2024 · 3 Wall Street analysts have issued 12-month price targets for Inhibrx's shares. Their INBX share price forecasts range from $35.00 to $60.00. On average, they expect … philipps holzkohle